Glutamate identified as predictor of disease progression in multiple sclerosis

(PhysOrg.com) -- UCSF researchers have identified a correlation between higher levels of glutamate, which occurs naturally in the brain as a byproduct of metabolism, and greater disease burden in multiple sclerosis patients. The study is the first to measure glutamate toxicity in the brain over time and suggests an improved method for tracking the disease and predicting its course.

Read the whole article on Physorg

More from Physorg